了解催产素受体变异对OXT-OXT受体结合的影响:一个数学模型
bioRxiv : the preprint server for biology
|April 1, 2024
概括
个性化催产素 (OXT) 剂量非常重要,因为反应是可变的. 一个新的数学模型预测了OXT受体的结合,使得OXT量身定制的剂量策略能够提高安全性和疗效.
科学领域:
- 药理学 药理学是指药理学的学科.
- 计算生物学 计算生物学
- 遗传学 是一个遗传学.
背景情况:
- 皮托 (合成氧化) 在分娩中被广泛使用,但可变剂量会带来安全风险.
- 了解催产素受体 (OXTR) 结合动态是优化OXT剂量的关键.
- 在OXTR的遗传变异可以显著影响OXT的疗效.
研究的目的:
- 开发一个数据驱动的数学模型,预测催产素-催产素受体 (OXT-OXTR) 结合动态.
- 为了研究常见的OXTR遗传变异对OXT结合的影响.
- 为个性化催产素剂量策略提供信息,以提高患者的安全性和治疗有效性.
主要方法:
- 开发了一个数学模型来预测OXT-OXTR结合,参数化与细胞特异的OXTR定位和分析的OXT-OXTR结合动力学.
- 在两种细胞类型中评估模型性能:HEK293T和人类肌体光滑肌细胞.
- 评估了五种普遍存在的OXTR变异 (V45L,P108A,L206V,V281M,E339K) 对OXT结合的影响.
主要成果:
- 该模型预测OXT受体的最大占用在10nM的肌体细胞和1μM的HEK293T细胞.
- OXTR变种V281M和E339K显著影响了OXT结合能力.
- 在早期治疗阶段增加OXT剂量可以在V281M和E339K变体中挽救衰弱的细胞反应.
结论:
- 计算框架使精确的催产素剂量策略成为可能.
- 基于遗传特征的个性化剂量可以提高治疗结果.
- 研究结果支持针对分娩和分娩进行量身定制的OXT管理,以提高母亲和婴儿的安全.
相关概念视频
The Two-State Receptor Model
1.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
1.9K
Quantitative Aspects of Drug-Receptor Interaction
977
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
977
Spare Receptors
3.6K
Some receptors remain unoccupied even when an agonist produces a maximal response. Such empty ones are called spare receptors. In presence of spare receptors the maximum effect of an agonist drug is achieved with fewer than 100% of the receptors being occupied. To determine the presence of spare receptors, scientists often compare the concentration of the drug needed to produce 50% of the maximum effect (EC50) with the concentration of the drug needed to occupy 50% of the receptors (Kd). If the...
3.6K
Drug-Receptor Interactions
5.2K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.2K
Opioid Receptors: Overview
776
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
776
The Equilibrium Binding Constant and Binding Strength
12.9K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
12.9K


